Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome
Status:
NOT_YET_RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the impact of nephrotic syndrome on the steady state pharmacokinetics and pharmacodynamics of edoxaban compared to health volunteers, and whether edoxaban can provide an equivalent anticoagulant effect to enoxaparin sodium.
Phase:
NA
Details
Lead Sponsor:
Peking University People's Hospital
Collaborator:
Chinese Academy of Medical Sciences, Fuwai Hospital